3:15 PM Beyond Traditional Endpoints: MRI in Rare & Genetic Kidney Disease Drug Development
Time: 3:15 pm
day: Conference Day 1
Details:
- The Power and Potential of Imaging in Kidney Disease Trials: Discover how advanced imaging can reveal subtle disease progression, measure treatment effects earlier than traditional endpoints, and deliver whole‑organ insights that complement biomarkers such as eGFR and proteinuria
- Current usage of kidney imaging in clinical trials: See how imaging is already shaping trials in ADPKD, CKD, and DKD by enabling precise, reproducible measurements of kidney volume, perfusion, and other structural and functional parameters across global sites
- Expanding Horizons: From Rare Kidney Diseases to Multi‑Organ Insights: Explore the potential of imaging endpoints in rare and genetic kidney diseases, and how integrating kidney imaging with assessments of metabolically linked organs like the heart and liver supports more holistic drug development strategies
